# Anticoagulation-free VV ECMO for Acute Respiratory Failure

> **NCT04273607** · PHASE2,PHASE3 · RECRUITING · sponsor: **Damian Ratano** · enrollment: 40 (estimated)

## Conditions studied

- Extracorporeal Membrane Oxygenation Complication

## Interventions

- **DRUG:** Subcutaneous Heparin

## Key facts

- **NCT ID:** NCT04273607
- **Lead sponsor:** Damian Ratano
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-01-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-01-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04273607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04273607, "Anticoagulation-free VV ECMO for Acute Respiratory Failure". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04273607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*